Literature DB >> 31149238

HEMOGLOBIN A1c LEVEL HIGHER THAN 9.05% CAUSES A SIGNIFICANT IMPAIRMENT OF ERYTHROCYTE DEFORMABILITY IN DIABETES MELLITUS.

Q Li1, L Z Yang1.   

Abstract

CONTEXT: Clinical studies demonstrated erythrocyte deformability (ED) is impaired in diabetic patients and described the correlations between HbA1c and ED. Few studies further investigated what an exact elevated HbA1c level linked to the impairment of ED in diabetes.
OBJECTIVE: This study was to determine a cut-off point of HbA1c level leading to the impairment of ED in patients with diabetes.
DESIGN: This was a retrospective observational study. ROC curve analysis was used to determine an optimal cut-off value of HbA1c for the increasing HSRV. SUBJECTS AND METHODS: In this study, 300 type 2 diabetic patients were enrolled. The whole blood viscosity was measured. High shear reductive viscosity (HSRV) was used to indirectly estimate ED. Based on the obtained cut-off value and glycemic control criteria for HbA1c, we divided all the cases into different groups to further confirm the accuracy of the cut-off value.
RESULTS: In 300 patients, ROC curve illustrated that 9.05% was the optimal cut-off value as a predictor of the increasing HSRV. And higher odds ratio (OR) for significant decrease in ED was seen in the patients with HbA1c >9.05% compared to those with HbA1c≤9.05% (OR: 3.78, 95% CI: 2.08-6.87). HSRV increased significantly in patients with HbA1c level >9.05% in comparison to patients with HbA1c levels <6.5% between 6.5 and 8.0% and between 8.0 and 9.05%.
CONCLUSION: ED decreased significantly in diabetic patients as soon as HbA1c level was higher than 9.05%.

Entities:  

Keywords:  Erythrocyte deformability; HbA1c; High shear reductive viscosity; Type 2 diabetes mellitus

Year:  2018        PMID: 31149238      PMCID: PMC6516603          DOI: 10.4183/aeb.2018.66

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  40 in total

Review 1.  The red blood cell in vascular occlusion.

Authors:  Saul Yedgar; Alexander Koshkaryev; Gregory Barshtein
Journal:  Pathophysiol Haemost Thromb       Date:  2002 Sep-Dec

2.  Effects of direct adsorption of lipoproteins apheresis on lipoproteins, low-density lipoprotein subtypes, and hemorheology in hypercholesterolemic patients with coronary artery disease.

Authors:  Carsten Otto; H Christian Geiss; Ester Laubach; Peter Schwandt
Journal:  Ther Apher       Date:  2002-04

3.  Direct measurement of erythrocyte deformability in diabetes mellitus with a transparent microchannel capillary model and high-speed video camera system.

Authors:  K Tsukada; E Sekizuka; C Oshio; H Minamitani
Journal:  Microvasc Res       Date:  2001-05       Impact factor: 3.514

4.  Rheological determinants of red blood cell aggregation in diabetic patients in relation to their metabolic control.

Authors:  K Elishkevitz; R Fusman; M Koffler; I Shapira; D Zeltser; D Avitzour; N Arber; S Berliner; R Rotstein
Journal:  Diabet Med       Date:  2002-02       Impact factor: 4.359

5.  The effects of cholesterol levels on hemorheological parameters in diabetic patients.

Authors:  Meltem Ercan; Dildar Konukoğlu; Tijen Erdem; Sinan Onen
Journal:  Clin Hemorheol Microcirc       Date:  2002       Impact factor: 2.375

6.  Blood rheology in patients with diabetes mellitus.

Authors:  C Le Dévéhat; M Vimeux; T Khodabandehlou
Journal:  Clin Hemorheol Microcirc       Date:  2004       Impact factor: 2.375

7.  Impaired erythrocyte deformability precedes vascular changes in experimental diabetes mellitus.

Authors:  E J Diamantopoulos; C Kittas; D Charitos; M Grigoriadou; G Ifanti; S A Raptis
Journal:  Horm Metab Res       Date:  2004-03       Impact factor: 2.936

8.  The association between erythrocyte internal viscosity, protein non-enzymatic glycosylation and erythrocyte membrane dynamic properties in juvenile diabetes mellitus.

Authors:  C Watala; H Witas; L Olszowska; W Piasecki
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

9.  Haemorheological variables in a rat model of hypertriglyceridaemic obesity and diabetes.

Authors:  G N Herńandez; C Dabin; M del C Gayol; M L Rasia
Journal:  Vet Res Commun       Date:  2002-12       Impact factor: 2.459

Review 10.  C-peptide, Na+,K(+)-ATPase, and diabetes.

Authors:  P Vague; T C Coste; M F Jannot; D Raccah; M Tsimaratos
Journal:  Exp Diabesity Res       Date:  2004 Jan-Mar
View more
  3 in total

1.  Evaluation of Red Blood Cell Parameters as a Biomarker for Long-Term Glycemic Control Monitoring Among Type 2 Diabetic Patients in Southwest Ethiopia: A Cross-Sectional Study.

Authors:  Misganaw Asmamaw; Tariku Sime; Kumsa Kene; Minale Fekadie Baye; Muluken Teshome; Belay Zawdie
Journal:  Diabetes Metab Syndr Obes       Date:  2021-12-30       Impact factor: 3.168

Review 2.  Erythrocytes: Central Actors in Multiple Scenes of Atherosclerosis.

Authors:  Chloé Turpin; Aurélie Catan; Olivier Meilhac; Emmanuel Bourdon; François Canonne-Hergaux; Philippe Rondeau
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

Review 3.  Metabolic Influences Modulating Erythrocyte Deformability and Eryptosis.

Authors:  Jean-Frédéric Brun; Emmanuelle Varlet-Marie; Justine Myzia; Eric Raynaud de Mauverger; Etheresia Pretorius
Journal:  Metabolites       Date:  2021-12-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.